Back to School: How biopharma can reboot drug development. Access exclusive analysis here

rhATIII: Phase III

In a 52-patient European Phase III trial, rhATIII treatment significantly reduced the use of fresh frozen

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE